Clinical and economic burden of chronic kidney disease in Medicare Fee-for-Service beneficiaries with and without comorbid type 2 diabetes and heart failure: A retrospective cohort study
Older adults with a new diagnosis of CKD experienced considerable clinical and economic burden, and presence of T2DM and HF was associated with larger burden. All-cause mean total costs at 12 months after a new diagnosis of CKD ranged from $24,180 for the CKD-only cohort to $54,477 for the CKD+HF+T2DM cohort.
Authors
- Lydia Yejin Lee (ORCID: https://orcid.org/0000-0002-4199-449X)
- Zachary A. Marcum (ORCID: https://orcid.org/0000-0002-4690-2304)
- Andrew J. Epstein (ORCID: https://orcid.org/0000-0001-5078-6564)
- Lindsay G.S. Bengtson (ORCID: https://orcid.org/0000-0002-5370-4090)
- Satabdi Chatterjee
Institutions
- Boehringer Ingelheim (United States) (US)
Publication Details
- Journal
- Journal of Managed Care & Specialty Pharmacy
- Published
- 2025-12-04
- DOI
- https://doi.org/10.18553/jmcp.2025.25167
- Primary Topic
- Chronic Kidney Disease and Diabetes
- Type
- article
- Field-Weighted Citation Impact
- 0.00